Zhang T, Zhou H, Xu M, Qian C, et al. Combination venetoclax and olverembatinib (HQP1351) as a successful therapeutic strategy for relapsed/refractory (R/R) mixed-phenotype blast phase of chronic myeloid leukemia. Ann Hematol 2023 Feb 6. doi: 10.1007/s00277-023-05110.
PMID: 36745193